Dexcom (DXCM) Total Liabilities (2010 - 2026)
Dexcom (DXCM) posted quarterly Total Liabilities of $3.8 billion for Q2 2026, down 19.35% year-over-year from $4.8 billion in Q2 2025, and up 4.28% quarter-over-quarter from $3.7 billion in Q1 2026.
Dexcom (DXCM) Total Liabilities (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Total Liabilities for 17 consecutive years, with $3.8 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Liabilities fell 19.35% year-over-year to $3.8 billion; the TTM figure through Jun 2026 stood at $3.8 billion (down 19.35% YoY), while the FY2025 annual figure was $3.6 billion, down 17.98% from the prior year.
- Total Liabilities climbed to $3.8 billion in Q2 2026 per DXCM's latest filing, from $3.7 billion in the prior quarter.
- Across five years, Total Liabilities topped out at $4.8 billion in Q3 2025 and bottomed at $2.9 billion in Q1 2022.
- Historically, Total Liabilities has averaged $4.0 billion across 5 years, with a median of $4.2 billion in 2023.
- Annual changes were most pronounced in 2023 — Total Liabilities surged 59.39% — and 2026, when it fell 19.35%.
- Dexcom's Total Liabilities stood at $3.3 billion in 2022, then increased by 28.71% to $4.2 billion in 2023, then gained by 4.43% to $4.4 billion in 2024, then slipped by 17.98% to $3.6 billion in 2025, then gained by 6.68% to $3.8 billion in 2026.
- Business Quant data shows DXCM's Total Liabilities at $3.8 billion in Q2 2026, $3.7 billion in Q1 2026, and $3.6 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 23.94 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 3.14 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 3.83 Bn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 26.03 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 17.70 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 3.51 Bn |
| 10 | Zimmer Biomet Holdings | 19.25 Bn | 18.84 Bn | 1.54 Bn | 10.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.83 Bn |
| Mar 31, 2026 | 3.68 Bn |
| Dec 31, 2025 | 3.59 Bn |
| Sep 30, 2025 | 4.77 Bn |
| Jun 30, 2025 | 4.75 Bn |
| Mar 31, 2025 | 4.49 Bn |
| Dec 31, 2024 | 4.38 Bn |
| Sep 30, 2024 | 4.37 Bn |
| Jun 30, 2024 | 4.36 Bn |
| Mar 31, 2024 | 4.24 Bn |
| Dec 31, 2023 | 4.20 Bn |
| Sep 30, 2023 | 4.33 Bn |
| Jun 30, 2023 | 4.72 Bn |
| Mar 31, 2023 | 3.28 Bn |
| Dec 31, 2022 | 3.26 Bn |
| Sep 30, 2022 | 3.07 Bn |
| Jun 30, 2022 | 2.96 Bn |
| Mar 31, 2022 | 2.87 Bn |
| Dec 31, 2021 | 2.89 Bn |
| Sep 30, 2021 | 2.64 Bn |